Probiota 2027 adds One Health to agenda

The event will address market trends, regulatory updates, scientific advances in microbiome research, and new approaches to metabolic and reproductive health, with a focus on the broader connections between human, animal, and environmental microbiomes.
The event will address market trends, regulatory updates, scientific advances in microbiome research, and new approaches to metabolic and reproductive health, with a focus on the broader connections between human, animal, and environmental microbiomes. (NutraIngredients)

Probiota 2027 will return to Berlin from Feb. 9–11 with a new three-day format and an expanded agenda that includes a full day dedicated to One Health.

The annual NutraIngredients event will bring together scientists, ingredient suppliers, brands and other stakeholders to discuss the latest developments in probiotics, prebiotics and postbiotics, as well as some of the questions facing the wider microbiome sector.

This year’s program is organized around three themes: Consumer Trends and Regulation, Science and Innovation, and One Health.

The business of biotics

The first day, Tuesday, February 9, will examine the state of the market, including category trends, emerging European markets, and perspectives from brands and retailers.

There will also be a focus on claims substantiation, an ongoing challenge for probiotic manufacturers navigating the complexities of clinical trial design, strain-specific evidence and regulatory requirements.

A separate panel will cover regulatory developments in Europe, North America and Asia-Pacific, including updates from the European Food Safety Authority (EFSA) and Australia.

Explore related questions

Probiota Pioneers, the event’s initiative for early-stage microbiome businesses, will also feature on the opening day.

Where is the science heading?

The second day will focus on areas of microbiome research that could have implications for future supplement development.

Women’s health is among them, with a session dedicated to Polyendocrine Metabolic Ovarian Syndrome (PMOS, formerly PCOS) and the evidence for microbiome-targeted approaches to metabolic, hormonal and reproductive health.

Another session will examine the gut-organ axes, including research into connections between the gut microbiome and the liver, lungs, muscles, skin and bones.

The program will also address the adolescent microbiome, with discussions around the potential role of biotics in digestive, immune, mood and metabolic health.

For those interested in earlier-stage research, a session on extracellular vesicles, quorum sensing and bacteriophages will consider how these mechanisms might be used to influence microbial communities.

A wider view of microbiome health

The final day marks a departure from the event’s more traditional focus on the human gut microbiome.

Under the One Health theme, speakers will examine the relationships between human, animal and environmental microbiomes, including how microbial exposure through soil, agriculture and the food chain may affect health.

The agenda also includes discussions around the holobiont concept, ecosystem restoration and the emerging debate over access to beneficial microbial exposure.

The addition brings environmental microbiology into a conversation that, for the supplement industry, has largely centered on human health and product applications.

Early Bird registration closes Monday, Dec. 7, 2026.

For further information, download the conference guide here.